Am J Pathol (2015) 185(1):18596.10.1016/j.ajpath.2014.09.010 97 Lehrskov-SchmidtLLehrskov-SchmidtLNielsenSTHolstJJMllerKSolomonTP
In large clinical trials, some people lost around 20 percent of their starting weight with tirzepatide
However, obesity treatment is now the fastest growing application segment
Phase 2 clinical literature (Jastreboff et al., NEJM, 2023
Any abrupt, intense abdominal pain on GLP1s warrants urgent evaluation rather than waiting to see if it passes. The GI falloutespecially prolonged vomiting and diarrheacan cause dehydration, low blood pressure, dizziness, and prerenal acute kidney injury
While you may recognize these active ingredients from diabetes treatments, they are prescribed under specific names when used for weight health